INFUSYSTEM HOLDINGS, INC Sales-type Lease, Lease Income
INFUSYSTEM HOLDINGS, INC (INFU) reported Sales-type Lease, Lease Income of $168.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SalesTypeLeaseLeaseIncome · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC sales-type lease, lease income for the quarter ending 2026-06-30 was $168.00K, a 68.00% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC sales-type lease, lease income for the quarter ending 2026-03-31 was $99.00K, a 12.50% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC sales-type lease, lease income for the quarter ending 2025-12-31 was $80.00K, a 57.22% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC sales-type lease, lease income for the quarter ending 2025-09-30 was $83.00K, a 35.66% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC sales-type lease, lease income for fiscal 2025 was $350.00K, a 51.19% decline from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC sales-type lease, lease income for fiscal 2024 was $717.00K, a 77.94% decline from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC sales-type lease, lease income for fiscal 2023 was $3.25M, a 4413.89% increase from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC sales-type lease, lease income for fiscal 2022 was $72.00K.
| Period end | Sales-type Lease, Lease Income 3 month | Sales-type Lease, Lease Income 6 month | Sales-type Lease, Lease Income 9 month | Sales-type Lease, Lease Income 12 month |
|---|---|---|---|---|
| 2026-06-30 | $168.00K 10-Q · filed 2026-08-04 | $267.00K 10-Q · filed 2026-08-04 | $347.00K derived: sum of 3 quarters · filed 2026-08-04 | $430.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $99.00K 10-Q · filed 2026-05-08 | $179.00K derived: sum of 2 quarters · filed 2026-05-08 | $262.00K derived: sum of 3 quarters · filed 2026-05-08 | $362.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $163.00K derived: sum of 2 quarters · filed 2026-02-27 | $263.00K derived: sum of 3 quarters · filed 2026-08-04 | $350.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | $83.00K 10-Q · filed 2025-11-04 | $183.00K derived: sum of 2 quarters · filed 2026-08-04 | $270.00K 10-Q · filed 2025-11-04 | $458.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $100.00K 10-Q · filed 2026-08-04 | $187.00K 10-Q · filed 2026-08-04 | $375.00K derived: sum of 3 quarters · filed 2026-08-04 | $504.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $88.00K 10-Q · filed 2026-05-08 | $275.00K derived: sum of 2 quarters · filed 2026-05-08 | $404.00K derived: sum of 3 quarters · filed 2026-05-08 | $548.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $187.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $316.00K derived: sum of 2 quarters · filed 2026-02-27 | $460.00K derived: sum of 3 quarters · filed 2026-02-27 | $717.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $129.00K 10-Q · filed 2025-11-04 | $273.00K derived: sum of 2 quarters · filed 2025-11-04 | $530.00K 10-Q · filed 2025-11-04 | $831.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $144.00K 10-Q · filed 2025-08-05 | $401.00K 10-Q · filed 2025-08-05 | $702.00K derived: sum of 3 quarters · filed 2025-08-05 | $1.83M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $257.00K 10-Q · filed 2025-05-08 | $558.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.68M derived: sum of 3 quarters · filed 2025-05-08 | $3.01M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $301.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $1.43M derived: sum of 2 quarters · filed 2025-03-11 | $2.76M derived: sum of 3 quarters · filed 2025-03-11 | $3.25M 10-K · filed 2025-03-11 |
| 2023-09-30 | $1.13M 10-Q · filed 2024-11-08 | $2.46M derived: sum of 2 quarters · filed 2024-11-08 | $2.95M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $1.33M 10-Q · filed 2024-08-09 | $1.82M 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $494.00K 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $72.00K 10-K · filed 2024-04-10 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |